Second, by using qRT-PCR and Western blot analyses, we found that the expressions of Ars2 in AML patients and AML cell lines were higher than that in healthy donors and normal CD34+ bone marrow cells. The gene discussed is CD34; the disease is acute myeloid leukemia.